Acceleron Pharma Inc.
ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF

Last updated:

Abstract:

In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma. Methods for dosing a patient with an ActRIIb antagonist are also provided.

Status:
Application
Type:

Utility

Filling date:

27 May 2020

Issue date:

22 Apr 2021